Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis-Reference-Cited by-同舟云学术

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis

Published:2021-08-21 Issue:5 Volume:74 Page:2452-2466
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kozumi Kazuhiro¹,Kodama Takahiro¹^ORCID,Murai Hiroki¹,Sakane Sadatsugu¹,Govaere Olivier²,Cockell Simon²,Motooka Daisuke³,Kakita Naruyasu⁴,Yamada Yukinori⁴,Kondo Yasuteru⁵^ORCID,Tahata Yuki¹,Yamada Ryoko¹,Hikita Hayato¹,Sakamori Ryotaro¹^ORCID,Kamada Yoshihiro⁶,Daly Ann K.²,Anstee Quentin M.²⁷^ORCID,Tatsumi Tomohide¹,Morii Eiichi⁸,Takehara Tetsuo¹

Affiliation:

1. Department of Gastroenterology and Hepatology Osaka University Graduate School of Medicine Suita Japan

2. Translational and Clinical Research Institute Faculty of Medical Sciences Newcastle University Newcastle Upon Tyne United Kingdom

3. Genome Information Research Center Research Institute for Microbial DiseasesOsaka University Suita Japan

4. Department of Gastroenterology and Hepatology Kaizuka City Hospital Osaka Japan

5. Department of Hepatology Sendai Kousei Hospital Sendai Japan

6. Department of Advanced Metabolic Hepatology Osaka University Graduate School of Medicine Suita Japan

7. Newcastle National Institute for Health Research Biomedical Research CentreNewcastle Upon Tyne Hospitals National Health Service Foundation Trust Newcastle Upon Tyne United Kingdom

8. Department of Pathology Osaka University Graduate School of Medicine Osaka Japan

Funder

Horizon 2020 Framework Programme

Innovative Medicines Initiative

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31995